Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga V Leontieva

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Cell Cycle (Georgetown, Tex.)|January 30, 2009
RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancerOlga V Leontieva, Yuri Ionov
The Journal of Biological Chemistry|November 26, 2003
Identification of two distinct pathways of protein kinase Calpha down-regulation in intestinal epithelial cellsOlga V Leontieva, Jennifer D Black
Cell Cycle (Georgetown, Tex.)|August 27, 2013
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversionOlga V Leontieva, Mikhail V Blagosklonny
Aging|January 13, 2017
Gerosuppression by pan-mTOR inhibitorsOlga V Leontieva, Mikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|February 6, 2014
M(o)TOR of pseudo-hypoxic state in aging: rapamycin to the rescueOlga V Leontieva, Mikhail V Blagosklonny
Oncotarget|January 10, 2018
While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblastsOlga V Leontieva, Mikhail V Blagosklonny
Aging|January 8, 2011
DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescenceOlga V Leontieva, Mikhail V Blagosklonny
Aging|December 14, 2011
Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppressionOlga V Leontieva, Mikhail V Blagosklonny
Aging|January 15, 2015
Gerosuppression in confluent cellsOlga V Leontieva, Mikhail V Blagosklonny
Oncotarget|January 15, 2015
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversionOlga V Leontieva, Mikhail V Blagosklonny
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|January 30, 2009
RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancerOlga V Leontieva, Yuri Ionov
The Journal of Biological Chemistry|November 26, 2003
Identification of two distinct pathways of protein kinase Calpha down-regulation in intestinal epithelial cellsOlga V Leontieva, Jennifer D Black
Cell Cycle (Georgetown, Tex.)|August 27, 2013
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversionOlga V Leontieva, Mikhail V Blagosklonny
Aging|January 13, 2017
Gerosuppression by pan-mTOR inhibitorsOlga V Leontieva, Mikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|February 6, 2014
M(o)TOR of pseudo-hypoxic state in aging: rapamycin to the rescueOlga V Leontieva, Mikhail V Blagosklonny
Oncotarget|January 10, 2018
While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblastsOlga V Leontieva, Mikhail V Blagosklonny
Aging|January 8, 2011
DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescenceOlga V Leontieva, Mikhail V Blagosklonny
Aging|December 14, 2011
Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppressionOlga V Leontieva, Mikhail V Blagosklonny
Aging|January 15, 2015
Gerosuppression in confluent cellsOlga V Leontieva, Mikhail V Blagosklonny
Oncotarget|January 15, 2015
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversionOlga V Leontieva, Mikhail V Blagosklonny
Pageof 4